Table 3. Estimated relative risk for decline of eGFR ≥ 40% by repeatedly measured albuminuria.
B | S.E. | EXP (B) | 95% CI of Wald | P value | ||
---|---|---|---|---|---|---|
Gender (female) | -0.232 | 0.772 | 0.792 | -1.746 | 1.282 | 0.764 |
Age (year) | 0.011 | 0.035 | 1.011 | -0.057 | 0.079 | 0.749 |
eGFR (ml/min/1.73 m2) | -0.043 | 0.020 | 0.976 | -0.083 | -0.003 | 0.035 |
Repeatedly measured albuminuria (per 500mg/day) | 0.375 | 0.107 | 1.455 | 0.165 | 0.585 | <0.001 |
eGFR, estimated glomerular filtration rate; S.E., standard error.
The model using the generalized estimating equations was adjusted for age, sex, and independent factors related to the risk of a decline of eGFR ≥ 40% such as eGFR level during the enrollment period of the trial phase.